Co-authored with Bill Wellman, adjunct faculty at Harvard University, where he teaches courses on innovation, entrepreneurship, and blockchain. He also is a principal with Philips Healthcare. This is part of a series examining how blockchain technology could be applied in the ...
Alt-currency in healthcare: Gold rush or fool’s gold?
The rise of alt-currencies in 2017 Bitcoin and other digital currencies have been exploding in 2017. On June 11th, Bitcoin crossed the $3,000 mark for the first time in history, according to the CoinDesk Bitcoin Price Index (BPI), before dropping 10 percent the following ...
Access and allies: The war over healthcare
I often wonder where the fight is more contentious: the one raging inside, or the one outside the healthcare system? The way that we talk about healthcare almost everywhere is remarkably zero-sum; it seems none of the stakeholders can conceive of the future of the system in a ...
Human risk in cybersecurity: The enemy within
Cyberattacks are in the news daily. Often the headlines sound alarms about hacktivists or hackers from across the globe, but shocking headlines overlook a key statistic: according to a 2016 report published by IBM (registration required), up to 60% of all cyberattacks result, ...
Why it could be prime time for Amazon to enter the pharmacy market
Would you like your medicine waiting for you at your door when you arrive home from surgery? Amazon may not only be delivering your goods and groceries, but also prescription medicines. Amazon is starting to make more concerted moves towards the multibillion dollar pharmacy ...
Diagnosis Overkill: How to do more about doing less?
This is the final post of a five-part series titled “Diagnosis Overkill.” “It isn’t enough to eliminate unnecessary care. It has to be replaced with necessary care.” – Dr. Atul Gawande Given the forces of business, technology, and science that are expanding medical ...
Diagnosis Overkill: Diagnosis genomics will break the medical diagnosis
This is the fourth installment of a five-part series titled “Diagnosis Overkill.” Genomic sequencing is playing a growing role in genetic sequencing for research and drug development. Today, patient testing is generally reserved for those who have already had a preliminary ...
Diagnosis Overkill: Chatbots and the diagnosis democracy
This is the third installment of a five-part series titled “Diagnosis Overkill.” Dr. Jay Parkinson of Sherpaa recently weighed in on the medical chatbot and the slow but steady automation of primary care. He notes the value proposition in deploying bot technology to do things ...
Diagnosis Overkill: Understanding overdiagnosis
This is the second installment of a five-part series titled “Diagnosis Overkill.” Why are so many Americans getting diagnosed and treated inappropriately in the first place? Dr. Hardeep Singh, a leading researcher in this space, breaks down how the process of diagnosing a ...
Diagnosis Overkill: Consumerism, bots, genomics, and the overtreatment epidemic
This is the first of a five-part series titled “Diagnosis Overkill.” Business and technology trends are disrupting the medical diagnosis as we know it. “Virtually every family in the country, the research indicates, has been subject to overtesting and overtreatment in one ...
- 1
- 2
- 3
- …
- 79
- Next Page »